Latest News

Novartis CEO: ‘We tried to do the right things’ in FDA data scandal

Novartis CEO Vas Narasimhan on Wednesday defended his company’s decision to wait three months to tell authorities about falsified data submitted to the Food and Drug Administration, saying the company “tried to do the right things” in the process.

He also said Novartis was now “in the process of exiting” a small number of scientists at AveXis, Novartis’s gene therapy business, who were “involved in these data inaccuracies.”

Read the rest…

Source link

Related posts

Ruthless meth networks get ill-prepared Myanmar hooked


1 in 6 insured hospital patients get a surprise bill for out-of-network care


Does Pubic Grooming Increase STI Risk?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World